Skip to main content

Featured

Daily Markets Update: TSX Hits Six-Week Low, Dow Sheds 849 Points as Nvidia Beat Lifts Asia

  Canadian Money Brief  |  Daily Markets Update Wednesday, November 18, 2026  •  Covers Tuesday’s closes plus Wednesday’s Asia and early Europe Canada’s main stock index closed Tuesday at 35,315.30 , down 1.14% . It was the TSX’s fourth straight decline and its lowest close in nearly six weeks, as a tech-led selloff rolled around the globe ahead of Nvidia’s earnings. On Wall Street, the Dow lost 848.75 points and the S&P 500 fell for a fourth straight session to its lowest close since late July. Then came the reversal. After the closing bell, Nvidia reported results and a forecast that both topped expectations, its shares jumped in after-hours trading, and Asian markets rebounded on Wednesday. Whether that relief lasts is the question for today, with Fed meeting minutes due at 2:00 p.m. ET. Markets at a Glance Market Level Change Canada (Tuesday close) S&P/TSX Composite 35,315.30 −406.83 (−1.14%) Canadian dollar 69.97¢ US (C$1.4293) +0.03¢ vs. Monday Ca...

article

Federal Government Boosts Vaccine Injury Compensation Fund with Additional $36 Million

 

The Canadian federal government has recently allocated an additional $36.4 million to the Vaccine Injury Compensation Fund, a program designed to support individuals who have experienced serious injuries or fatalities related to vaccines since the end of 2020. Here are the key details:

  1. Purpose of the Fund:

    • The program was established shortly after COVID-19 vaccines became available to the public.
    • It provides financial compensation to people who suffered adverse effects due to Health Canada-approved vaccines.
    • The goal is to assist those who were seriously impacted by vaccination.
  2. Funding and Administration:

    • The Liberal government initially earmarked $75 million for the first five years of the program.
    • A private firm called OXARO manages the program and disburses valid claims originating outside of Quebec.
    • To date, OXARO has received $56.2 million from Ottawa and has paid out $11.2 million in compensation.
    • Quebec has its own vaccine injury compensation program, which received $7.75 million when the federal program launched.
  3. Recent Funding Boost:

    • As part of the federal budget, the government allocated an additional $36 million to OXARO and Quebec.
    • This funding covers the next two years of the program.
    • The Public Health Agency of Canada contracted OXARO to ensure an impartial claims process.
  4. Eligibility and Claims:

    • The program covers injuries and deaths associated with vaccines approved for any illness.
    • Eligibility criteria include severe, life-threatening, or life-altering injuries resulting in disability, incapacity, birth defects, or death.
    • The available statistics do not specify which vaccines were involved.
  5. Rare Adverse Reactions:

    • Serious adverse reactions to vaccines are extremely rare (affecting less than one in a million people).
    • Nevertheless, the government recognizes its duty to provide support when such reactions occur.
    • Ottawa has also made COVID-19 vaccination mandatory for travel and federal public service employment.

In summary, the additional funding aims to ensure that those affected by vaccine-related injuries receive appropriate compensation while maintaining an impartial claims process. The program underscores the importance of vaccine safety and accountability in public health efforts. 


Comments